USPTO serial 79186212
CHIPMENTATION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 20, 2016
- Examiner
- PHILLIPS, WENDELL SHARMAN
- Law office
- —
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CHIPMENTATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $650
Owner
CeMM - Forschungszentrum für Molekulare Medizin GmbH
AT
Other trademarks owned by CeMM - Forschungszentrum für Molekulare Medizin GmbH
CeMM - Forschungszentrum für Molekulare Medizin GmbH
AT
Other trademarks owned by CeMM - Forschungszentrum für Molekulare Medizin GmbH
CeMM - Forschungszentrum für Molekulare Medizin GmbH
AT
Other trademarks owned by CeMM - Forschungszentrum für Molekulare Medizin GmbH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Catherine F. Hoffman
Catherine F. Hoffman Baker, Donelson, Bearman, Caldwell, & Berkowitz, PC200 East Broward Blvd, Suite 2000Ft. Lauderdale, FL 33301United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for use in DNA analysis other than for medical use; reagents for use in scientific apparatus for chemical or biological analysis; biomolecule labeling kits comprising reagents for use in scientific research; chemicals for use in immuno-assay testing other than for medical or veterinary use; in-vivo diagnostic reagents for scientific use; diagnostic testing preparations, other than for medical use; diagnostic preparations, except for medical or veterinary use; diagnostic reagents, other than for medical laboratory use; diagnostic reagents, except for medical or veterinary use; diagnostic reagents for in-vitro use, other than for medical use; diagnostic chemicals, other than for medical or veterinary use; diagnostic preparations, other than for medical or veterinary purposes; clinical diagnostic preparations, other than for medical or veterinary use; diagnostic reagents and preparations, except for medical or veterinary use; diagnostic reagents, other than for medical use for sale in kit form; diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology; diagnostic preparations for scientific or research use other than for medical use; reagents for use in diagnostic tests, other than for medical or veterinary purposes; chemical reagents for use in diagnostic tests, other than for medical or veterinary use; diagnostic substances in the nature of chemicals and preparations, other than for medical use; diagnostic reagents for scientific or research use; diagnostic preparations for scientific or research use; biochemical products, in particular biochemicals used in industry and science to study cells, chromatin, proteins, nucleic acids, protein-nucleic acid interactions, other than for medical use; biochemical reagents and chemical reagents, in particular biochemical reagents and chemical reagents for in-vitro use in laboratories for scientific use | ACTIVE | — |
| 009 | [ Apparatus, namely, column- and magnet-based apparatus for chromatin immunoprecipitation, chromatin analysis, chromatin purification, nucleic acid purification and analysis for laboratory use; scientific, electric, photographic, optical, measuring apparatus, namely, sequencers for next generation genetic sequencing for laboratory use; scientific, electric apparatus preparing nucleic acids for sequencing for laboratory use; computer hardware and computer software for processing and displaying and interpreting data, in particular for scientific purposes; testing apparatus for testing samples comprising a nucleic acid for for diagnostic purposes, other than medical purposes ] | SECTION 71 - CANCELLED | — |
| 040 | [ Treatment of nucleic acids, proteins and chromatin; treatment of nucleic acids with enzymatic reactions; treatment of chromatin with enzymatic reactions; treatment of nucleic acids for sequencing ] | SECTION 71 - CANCELLED | — |
| 042 | [ Scientific research and development services; industrial research in the field of biology; industrial research in the field of human biology and diseases like cancer and inflammation and immune disorders; laboratory services for detecting protein-DNA interactions; Laboratory analysis relating to protein-DNA interactions; computer programming; DNA screening for scientific research purposes; biochemical analysis; biological analysis; preparation of biological samples for analysis in research laboratories; preparation of biological samples for testing and analysis in research laboratories; research and development in the field of diagnostic preparations ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CeMM - Forschungszentrum für Molekulare Medizin GmbH
- Other trademarks owned by CeMM - Forschungszentrum für Molekulare Medizin GmbH
- Other trademarks owned by CeMM - Forschungszentrum für Molekulare Medizin GmbH
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named CHIPMENTATION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2026 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Dec 20, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Nov 14, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 8, 2025 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 11, 2024 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Dec 11, 2024 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Nov 27, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 26, 2024 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Mar 26, 2024 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Feb 26, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 26, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 26, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 26, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 26, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 20, 2023 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Dec 20, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 19, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 19, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 4, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 21, 2017 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 21, 2017 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Mar 20, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 20, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 11, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 4, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 4, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 14, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 14, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 14, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 29, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 20, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 16, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 16, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2016 | ALIE | ASSIGNED TO LIE | — |
| Jul 29, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 20, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 31, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 31, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 28, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 27, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 23, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 26, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 22, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 21, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |